UA94869C2 - Use of lipoflavon as agent for treatment of acute cerebral trauma - Google Patents

Use of lipoflavon as agent for treatment of acute cerebral trauma

Info

Publication number
UA94869C2
UA94869C2 UAA201008130A UAA201008130A UA94869C2 UA 94869 C2 UA94869 C2 UA 94869C2 UA A201008130 A UAA201008130 A UA A201008130A UA A201008130 A UAA201008130 A UA A201008130A UA 94869 C2 UA94869 C2 UA 94869C2
Authority
UA
Ukraine
Prior art keywords
lipoflavon
treatment
agent
acute cerebral
cerebral trauma
Prior art date
Application number
UAA201008130A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Станислав Александрович Жиляев
Сергей Юрьевич Штриголь
Original Assignee
Национальный Фармацевтический Университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Фармацевтический Университет filed Critical Национальный Фармацевтический Университет
Priority to UAA201008130A priority Critical patent/UA94869C2/en
Publication of UA94869C2 publication Critical patent/UA94869C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to pharmacy and medicine, namely to agents with cerebroprotective action, in particular lipoflavon, which can be used for treatment of acute cerebral failure caused by traumatic brain injury, in order to expand the arsenal of effective drugs having cerebroprotective action.
UAA201008130A 2010-06-29 2010-06-29 Use of lipoflavon as agent for treatment of acute cerebral trauma UA94869C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201008130A UA94869C2 (en) 2010-06-29 2010-06-29 Use of lipoflavon as agent for treatment of acute cerebral trauma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201008130A UA94869C2 (en) 2010-06-29 2010-06-29 Use of lipoflavon as agent for treatment of acute cerebral trauma

Publications (1)

Publication Number Publication Date
UA94869C2 true UA94869C2 (en) 2011-06-10

Family

ID=50833920

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201008130A UA94869C2 (en) 2010-06-29 2010-06-29 Use of lipoflavon as agent for treatment of acute cerebral trauma

Country Status (1)

Country Link
UA (1) UA94869C2 (en)

Similar Documents

Publication Publication Date Title
TN2015000278A1 (en) Autotaxin inhibitors
WO2014062720A3 (en) Methods of treating cancer
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
HK1210599A1 (en) Abuse deterrent pharmaceutical compositions for controlled release
IL231536A (en) Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases
PH12015500115A1 (en) Glucagon analogues
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
HK1213552A1 (en) Substituted benzene compounds
MX2014008705A (en) Tricyclic sulfone compounds and methods of making and using same.
MX2014008706A (en) Tricyclic sulfonamide compounds and methods of making and using same.
IL251543B (en) Use of a topical gel composition in the manufacture of a medicament for the prevention or treatment of a skin disorder
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
TN2015000255A1 (en) Chitin or derivatives thereof for the prevention and/or treatment of parasitoses
PL2857037T3 (en) Agent for preventing and/or treating peripheral neuropathic pain caused by anti-cancer drug
PT2774991T (en) Drug delivery system for use in the treatment or diagnosis of neurological disorders
MX2015005732A (en) Tricyclic compounds and methods of making and using same.
HK1209672A1 (en) Treatment of multiple sclerosis with combination of laquinimod and fampridine
MX364528B (en) Withanolides useful for the treatment of neurodegenerative diseases.
MX2015005733A (en) Tricyclic compounds for use in the treatment and/or control of obesity.
IN2014DN03010A (en)
WO2013038200A3 (en) Neurodevelopmental disorders
UA115307C2 (en) APPLICATION OF MEDICINAL PRODUCT CONTAINING RECOMBINANT LECTIN MELINES FOR TREATMENT OF SKIN CANCER
UA94869C2 (en) Use of lipoflavon as agent for treatment of acute cerebral trauma
PT2686005T (en) Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain
UA56015U (en) use of glucosamine derivatives as cerebroprotective agents